Predictive factors for the efficacy of brolucizumab in refractory polypoidal choroidal vasculopathy following aflibercept resistance - Akie Yoshinaga; Kohdai Kitamoto; Shuichiro Aoki; Ryo Terao; Tatsuya Inoue; Ryo Obata; Keiko Azuma (PLoS ONE, 2025)